 A STUDY OF THE SAFETY, PHARMACOKINETICS, AND THERAPEUTIC ACTIVITY OF RO6958688 IN COMBINATION WITH ATEZOLIZUMAB IN PARTICIPANTS WITH LOCALLY ADVANCED ANDOR METASTATIC CARCINOEMBRYONIC ANTIGEN CEA-POSITIVE SOLID TUMORS: 